These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3551350)

  • 41. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
    Rasmussen FV; Waldorff S; Madsen L
    Eur J Respir Dis; 1984 Jan; 65(1):20-7. PubMed ID: 6705854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy using delayed-action theophylline].
    Ulmer WT; Zimmermann I
    Fortschr Med; 1982 Nov; 100(42):1973-6. PubMed ID: 7152431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of ketotifen and aminophylline on the central and peripheral airways.
    Dorow P; Schiess W
    Arzneimittelforschung; 1983; 33(2):265-8. PubMed ID: 6682668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
    Clark CJ; Boyd G
    Br J Clin Pharmacol; 1980 Apr; 9(4):359-64. PubMed ID: 7378251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oral administration of delayed-action aminophylline: analysis of blood levels after multiple doses in aged patients].
    Guggino G; Ricca Rossellini S
    G Clin Med; 1982 May; 63(5):337-45. PubMed ID: 7141176
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of oral aminophylline on lung mucociliary clearance in man.
    Sutton PP; Pavia D; Bateman JR; Clarke SW
    Chest; 1981 Dec; 80(6 Suppl):889-92. PubMed ID: 7030662
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pharmacokinetics and pharmacodynamics of proxyphylline in asthmatic children].
    Kalla M; Richter O; Reinhardt D
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):520-6. PubMed ID: 4047067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 58. [Controlled treatment with a retard theophylline preparation].
    Wilke A; Iwainsky H; Kulpe K
    Prax Klin Pneumol; 1988 Jul; 42(7):603-5. PubMed ID: 3186668
    [No Abstract]   [Full Text] [Related]  

  • 59. [Efficacy of theophylline aerosols in obstructive lung diseases (author's transl)].
    Kandt D; Ivainsky H; Sehrt I
    Respiration; 1981; 42(4):278-82. PubMed ID: 7330471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
    Cazzola M; Matera MG; Paternò E; Scaglione F; Santangelo G; Rossi F
    J Chemother; 1991 Aug; 3(4):240-4. PubMed ID: 1779258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.